Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):e133-4. doi: 10.1161/01.ATV.0000179009.60612.28.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Amides
  • Carrier Proteins / antagonists & inhibitors*
  • Carrier Proteins / metabolism
  • Cholesterol / metabolism
  • Cholesterol Ester Transfer Proteins
  • Esters
  • Female
  • Glycoproteins / antagonists & inhibitors*
  • Glycoproteins / metabolism
  • Humans
  • Male
  • Middle Aged
  • Sulfhydryl Compounds / administration & dosage*
  • Tangier Disease / drug therapy*
  • Tangier Disease / metabolism
  • Treatment Outcome

Substances

  • Amides
  • CETP protein, human
  • Carrier Proteins
  • Cholesterol Ester Transfer Proteins
  • Esters
  • Glycoproteins
  • Sulfhydryl Compounds
  • dalcetrapib
  • Cholesterol